Skip to main content

Table 2 Intraindividual comparison of lesion uptake FDG vs. Pentixafor

From: Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach

Patient no.

Localization of the lesion

Quantitative analyses

Visual analyses

Adeno/SCC

CXCR4 expressionb

FDG SUVmax

Pentixafor SUVmax

FDGa

Pentixafora

#1

paratracheal left

2.2

5.2

0

2

SCC

1

#2

mediastinal

10.1

3.2

2

0

SCC

4

infraclavicular

3.4

4.5

2

1

#3

hip

7.1

2.7

2

2

Adeno

1

thigh

10.5

3.9

2

2

adrenal gland left

3.3

2.9

2

2

left paraaortal lymph node

3.3

1.3

1

0

#4

esophagus

7.3

5.9

2

2

SCC

3

coeliacal

9,0

5,2

2

2

axillary right

0,85

1,73

0

2

hilary right

2,0

3,5

0

2

gastric curvature

5,6

4,1

2

2

#5

esophagus

6.6

6.5

2

2

Adeno

0

#6

mediastinal

14.4

4.2

2

0

Adeno

2

#7

mediastinal

15.8

4.8

2

2

SCC

3

#8

adrenal gland left

2.5

5.0

2

1

SCC

4

esophagus

3.3

3.9

1

0

lung upper lobe

4.9

1.5

2

0

#9

adrenal gland left

2.7

12.0

0

2

SCC

2

#10

infracarinal

2.7

9.1

0

2

SCC

4

mediastinal

4.1

9.8

1

2

supra right

2.2

5.4

0

2

supra left

2.8

6.6

0

2

esophagus

14.4

3.7

2

1

rib left

9.2

3.8

2

1

cervical left

13.7

4.1

2

1

SUM

26

  1. Adeno Adenocarcinoma, MPB Mediastinal blood pool, SCC Squamous cell cancer
  2. 0= < MBP, 1 ≥ MBP, 2 ≤ Liver
  3. b 0 = no CXCR4; 1 = low CXCR4; 2 = intermediate; 3 = strong; 4 = not available